Barbara Pahud, a native from Mexico City, completed her pediatric residency training in 2006 at the Infants and Children’s Hospital of Brooklyn (Maimonides Medical Center). She then joined the Stanford-Lucile Packard Children’s Hospital (LPCH) Vaccine Program as a postdoctoral fellow. In 2007, she started subspecialty training in Pediatric Infectious Diseases at the University of California, San Francisco. In 2008, she was selected for the Vaccine Safety Fellowship Program, coordinated with the Clinical Immunization Safety Assessment (CISA) Network and sponsored by the Immunization Safety Office (ISO) at the Centers for Disease Control and Prevention (CDC). As a vaccine safety fellow during the 2009 H1N1 pandemic, she was actively involved in surveillance studies to monitor the safety of the H1N1 vaccines.
Dr. Pahud joined the faculty of the Division of Infectious Diseases at Children’s Mercy Hospital in Kansas City in 2011. She is also an associate professor of Pediatrics at the University of Missouri-Kansas City School of Medicine and the University of Kansas Medical Center. Currently, she is the associate director of the NIH’s Vaccine Treatment and Evaluation Unit (VTEU) at Children’s Mercy Hospital and Director of the Kansas City IDEA state Pediatric Clinical Trials Network (ISPCTN), also funded by NIH. She is an active investigator for the CDC’s New Vaccine Surveillance Network (NVSN), and a principal investigator in multiple industry-sponsored clinical trials involving drugs and vaccines for children. Dr. Pahud’s research focuses on clinical trials, vaccine safety, immunization implementation, vaccine education, and promotion of research in underserved areas. Her most recent investigator-initiated project includes creation of the Collaboration for Vaccine Education and Research (CoVER) that has developed and implemented a vaccine education curriculum for pediatric and family medicine residency programs across the country.